Suppression of esophageal cancer cell growth using curcumin, (-)-epigallocatechin-3-gallate and lovastatin

doi:10.3748/wjg.v18.i2.126

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6063)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series.

Item

Count

PDF

578

HTML

5183

Figures (1-6)

302

Sum=6063

Jan 14, 2012 (publication date) through Nov 28, 2024

Times Cited of This Article

Times Cited (66)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Jan 14, 2012; 18(2): 126-135
Published online Jan 14, 2012. doi: 10.3748/wjg.v18.i2.126

Full Size Figure Download Figure

Figure 6 Expression of phosphorylated extracellular-signal-regulated kinases and cyclooxygenase-2 in esophageal cancer specimens. Paraffin sections of esophageal cancer tissues were immunostained with anti-phosphorylated extracellular-signal-regulated kinases (Erk1/2) or cyclooxygenase-2 (COX-2) antibody. Representative images were obtained from these tissue sections. SCC: Squamous cell carcinoma.

Citation: Ye F, Zhang GH, Guan BX, Xu XC. Suppression of esophageal cancer cell growth using curcumin, (-)-epigallocatechin-3-gallate and lovastatin. World J Gastroenterol 2012; 18(2): 126-135
URL: https://www.wjgnet.com/1007-9327/full/v18/i2/126.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i2.126